en
Scientific article
Letter
English

Risankizumab for pityriasis rubra pilaris

Published inClinical and experimental dermatology, vol. 46, no. 7, p. 1322-1324
Publication date2021-10
First online date2021-06-13
Keywords
  • Adult
  • Antibiotics, Antitubercular / therapeutic use
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use
  • Female
  • Humans
  • Injections, Subcutaneous
  • Latent Tuberculosis / complications
  • Latent Tuberculosis / drug therapy
  • Pityriasis Rubra Pilaris / complications
  • Pityriasis Rubra Pilaris / drug therapy
  • Pityriasis Rubra Pilaris / pathology
  • Rifampin / therapeutic use
Citation (ISO format)
BROCCO, Elise, LAFFITTE, Emmanuel Alexis. Risankizumab for pityriasis rubra pilaris. In: Clinical and experimental dermatology, 2021, vol. 46, n° 7, p. 1322–1324. doi: 10.1111/ced.14715
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0307-6938
103views
0downloads

Technical informations

Creation03/11/2022 1:31:00 PM
First validation03/11/2022 1:31:00 PM
Update time03/16/2023 2:56:50 AM
Status update03/16/2023 2:56:49 AM
Last indexation05/06/2024 10:30:31 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack